Tiziana Life Sciences (TLSA) Shares Outstanding (2017 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Shares Outstanding (Entity) of $118.3 million for Q4 2025, up 10.88% year-over-year from $106.7 million in Q4 2024, and up 1.25% quarter-over-quarter from $116.8 million in Q2 2025.
Tiziana Life Sciences (TLSA) Shares Outstanding (2017 - 2025) Analysis & Trends
Tiziana Life Sciences' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $118.3 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 10.88% year-over-year to $118.3 million; the TTM figure through Dec 2025 stood at $118.3 million (up 10.88% YoY), while the FY2025 annual figure was $118.3 million, up 10.88% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $118.3 million, up from $116.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $150.2 million in Q2 2021, with the low at $97.9 million in Q4 2021.
- The 5-year median for Shares Outstanding (Entity) is $102.8 million (2023), against an average of $109.7 million.
- The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) climbed 15.85% in 2021, then plunged 34.81% in 2022.
- Tiziana Life Sciences' Shares Outstanding (Entity) stood at $97.9 million in 2021, then advanced by 3.67% to $101.5 million in 2022, then climbed by 0.93% to $102.5 million in 2023, then rose by 4.1% to $106.7 million in 2024, then gained by 10.88% to $118.3 million in 2025.
- Business Quant data shows TLSA's Shares Outstanding (Entity) at $118.3 million in Q4 2025, $116.8 million in Q2 2025, and $106.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - | 118.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 118.28 Mn |
| Jun 30, 2025 | 116.83 Mn |
| Dec 31, 2024 | 106.67 Mn |
| Jun 30, 2024 | 103.10 Mn |
| Dec 31, 2023 | 102.47 Mn |
| Jun 30, 2023 | 102.27 Mn |
| Dec 31, 2022 | 101.53 Mn |
| Jun 30, 2022 | 97.93 Mn |
| Dec 31, 2021 | 97.93 Mn |
| Jun 30, 2021 | 150.22 Mn |
| Dec 31, 2020 | 84.53 Mn |
| Jun 30, 2020 | 150.22 Mn |
| Dec 31, 2019 | 27.30 Mn |
| Jun 30, 2019 | 12.60 Mn |
| Dec 31, 2018 | 12.76 Mn |
| Jun 30, 2018 | 12.60 Mn |
| Dec 31, 2017 | 10.64 Mn |